Differential expression profiles of the transcriptome in bone marrow‑derived cells in lung cancer revealed by next generation sequencing and bioinformatics

Chang,Wei‑An; Tsai,Ying‑Ming; Tsai,Yu‑Chen; Wu,Cheng‑Ying; Chang,Kuo‑Feng; Lien,Chi‑Tun; Hung,Jen‑Yu; Hsu,Ya‑Ling; Kuo,Po‑Lin

doi:10.3892/ol.2019.10085

Differential expression profiles of the transcriptome in bone marrow‑derived cells in lung cancer revealed by next generation sequencing and bioinformatics

Authors:
- Wei‑An Chang
- Ying‑Ming Tsai
- Yu‑Chen Tsai
- Cheng‑Ying Wu
- Kuo‑Feng Chang
- Chi‑Tun Lien
- Jen‑Yu Hung
- Ya‑Ling Hsu
- Po‑Lin Kuo
View Affiliations

Affiliations: Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan, R.O.C., Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan, R.O.C., Welgene Biotech, Inc., Taipei 115, Taiwan, R.O.C., Department of Internal Medicine, Kaohsiung Municipal United Hospital, Kaohsiung 804, Taiwan, R.O.C., Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan, R.O.C.
Published online on: February 28, 2019 https://doi.org/10.3892/ol.2019.10085
Pages: 4341-4350
Copyright: © Chang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

A pre‑metastatic niche (PMN) facilitates cancer metastasis through mobilization and recruitment of bone marrow‑derived cells (BMDCs) and associated factors. In bone marrow, hematogenous cells, including osteoclasts, macrophages and lymphocytes, and mesenchymal cells, including mesenchymal stem cells, osteoblasts and adipocytes, are involved in PMN formation. Patients with lung cancer and metastasis have a poor prognosis and shortened median survival time. Bone marrow has been considered fertile ground for dormant and proliferating tumor cells, and mobilizing and recruiting BMDCs and immune cells can establish a PMN. However, the role of BMDCs in PMN formation is not yet fully understood. The present study aimed to investigate the association between BMDCs and PMN in bone marrow tissue samples. The results demonstrated that bone marrow served an important role in lung cancer progression and that eight pathways were potentially involved, including ‘T‑cell receptor signaling pathway’, ‘osteoclast differentiation’, ‘MAPK signaling pathway’, ‘VEGF signaling pathway’, ‘leukocyte transendothelial migration’, ‘signaling pathways regulating the pluripotency of stem cells’, ‘oxytocin signaling pathway’ and ‘cell adhesion molecules (CAMs)’. In addition, the present study investigated the role of BMDCs in facilitating lung cancer metastasis. In conclusion, the results from the present study suggested that molecular alterations in gene expression may provide a novel signature in lung cancer, which may aid in the development of novel diagnostic and therapeutic strategies for patients with lung cancer and bone metastasis.

View Figures

View References

1	Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, MacDonald DD, Jin DK, Shido K, Kerns SA, et al: VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. 438:820–827. 2005. View Article : Google Scholar : PubMed/NCBI
2	Riihimäki M, Hemminki A, Fallah M, Thomsen H, Sundquist K, Sundquist J and Hemminki K: Metastatic sites and survival in lung cancer. Lung Cancer. 86:78–84. 2014. View Article : Google Scholar : PubMed/NCBI
3	Coleman RE: Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 12:6243s–6249s. 2006. View Article : Google Scholar : PubMed/NCBI
4	Peinado H, Zhang H, Matei IR, Costa-Silva B, Hoshino A, Rodrigues G, Psaila B, Kaplan RN, Bromberg JF, Kang Y, et al: Pre-metastatic niches: Organ-specific homes for metastases. Nat Rev Cancer. 17:302–317. 2017. View Article : Google Scholar : PubMed/NCBI
5	Kaplan RN, Psaila B and Lyden D: Bone marrow cells in the ‘pre-metastatic niche’: Within bone and beyond. Cancer Metastasis Rev. 25:521–529. 2006. View Article : Google Scholar : PubMed/NCBI
6	Roato I: Bone metastases: When and how lung cancer interacts with bone. World J Clin Oncol. 5:149–155. 2014. View Article : Google Scholar : PubMed/NCBI
7	Bergfeld SA and DeClerck YA: Bone marrow-derived mesenchymal stem cells and the tumor microenvironment. Cancer Metastasis Rev. 29:249–261. 2010. View Article : Google Scholar : PubMed/NCBI
8	Rutkowski MR, Svoronos N, Perales-Puchalt A and Conejo-Garcia JR: The tumor macroenvironment: Cancer-promoting networks beyond tumor beds. Adv Cancer Res. 128:235–262. 2015. View Article : Google Scholar : PubMed/NCBI
9	Liu Y and Cao X: Characteristics and significance of the pre-metastatic niche. Cancer Cell. 30:668–681. 2016. View Article : Google Scholar : PubMed/NCBI
10	Liu X and Quan N: Immune cell isolation from mouse femur bone marrow. Bio Protoc. 5:e16312015. View Article : Google Scholar : PubMed/NCBI
11	Sheu CC, Tsai MJ, Chen FW, Chang KF, Chang WA, Chong IW, Kuo PL and Hsu YL: Identification of novel genetic regulations associated with airway epithelial homeostasis using next-generation sequencing data and bioinformatics approaches. Oncotarget. 8:82674–82688. 2017. View Article : Google Scholar : PubMed/NCBI
12	Chen SC, Chen FW, Hsu YL and Kuo PL: Systematic analysis of transcriptomic profile of renal cell carcinoma under long-term hypoxia using next-generation sequencing and bioinformatics. Int J Mol Sci. 18:E26572017. View Article : Google Scholar : PubMed/NCBI
13	Bolger AM, Lohse M and Usadel B: Trimmomatic: A flexible trimmer for illumina sequence data. Bioinformatics. 30:2114–2120. 2014. View Article : Google Scholar : PubMed/NCBI
14	Friedlander MR, Mackowiak SD, Li N, Chen W and Rajewsky N: miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades. Nucleic Acids Res. 40:37–52. 2012. View Article : Google Scholar : PubMed/NCBI
15	Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR, Pimentel H, Salzberg SL, Rinn JL and Pachter L: Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc. 7:562–578. 2012. View Article : Google Scholar : PubMed/NCBI
16	Vejnar CE and Zdobnov EM: MiRmap: Comprehensive prediction of microRNA target repression strength. Nucleic Acids Res. 40:11673–11683. 2012. View Article : Google Scholar : PubMed/NCBI
17	Brownlie RJ and Zamoyska R: T cell receptor signalling networks: Branched, diversified and bounded. Nat Rev Immunol. 13:257–269. 2013. View Article : Google Scholar : PubMed/NCBI
18	Huse M: The T-cell-receptor signaling network. J Cell Sci. 122:1269–1273. 2009. View Article : Google Scholar : PubMed/NCBI
19	Niyongere S, Saltos A and Gray JE: Immunotherapy combination strategies (non-chemotherapy) in non-small cell lung cancer. J Thorac Dis. 10:S433–S450. 2018. View Article : Google Scholar : PubMed/NCBI
20	Reungwetwattana T and Dy GK: Targeted therapies in development for non-small cell lung cancer. J Carcinog. 12:222013. View Article : Google Scholar : PubMed/NCBI
21	Zhu ZJ and He JK: TINCR facilitates non-small cell lung cancer progression through BRAF-activated MAPK pathway. Biochem Biophys Res Commun. 497:971–977. 2018. View Article : Google Scholar : PubMed/NCBI
22	Burotto M, Chiou VL, Lee JM and Kohn EC: The MAPK pathway across different malignancies: A new perspective. Cancer. 120:3446–3456. 2014. View Article : Google Scholar : PubMed/NCBI
23	Farahani E, Patra HK, Jangamreddy JR, Rashedi I, Kawalec M, Rao Pariti RK, Batakis P and Wiechec E: Cell adhesion molecules and their relation to (cancer) cell stemness. Carcinogenesis. 35:747–759. 2014. View Article : Google Scholar : PubMed/NCBI
24	Schneider JG, Amend SR and Weilbaecher KN: Integrins and bone metastasis: Integrating tumor cell and stromal cell interactions. Bone. 48:54–65. 2011. View Article : Google Scholar : PubMed/NCBI
25	Schwankhaus N, Gathmann C, Wicklein D, Riecken K, Schumacher U and Valentiner U: Cell adhesion molecules in metastatic neuroblastoma models. Clin Exp Metastasis. 31:483–496. 2014. View Article : Google Scholar : PubMed/NCBI
26	Ihn HJ, Kim JA, Bae YC, Shin HI, Baek MC and Park EK: Afatinib ameliorates osteoclast differentiation and function through downregulation of RANK signaling pathways. BMB Rep. 50:150–155. 2017. View Article : Google Scholar : PubMed/NCBI
27	Niu G and Chen X: Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy. Curr Drug Targets. 11:1000–1017. 2010. View Article : Google Scholar : PubMed/NCBI
28	Jin GH, Xu W, Shi Y and Wang LB: Celecoxib exhibits an anti-gastric cancer effect by targeting focal adhesion and leukocyte transendothelial migration-associated genes. Oncol Lett. 12:2345–2350. 2016. View Article : Google Scholar : PubMed/NCBI
29	Kashyap V, Rezende NC, Scotland KB, Shaffer SM, Persson JL, Gudas LJ and Mongan NP: Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs. Stem Cells Dev. 18:1093–1108. 2009. View Article : Google Scholar : PubMed/NCBI
30	Cassoni P, Sapino A, Marrocco T, Chini B and Bussolati G: Oxytocin and oxytocin receptors in cancer cells and proliferation. J Neuroendocrinol. 16:362–364. 2004. View Article : Google Scholar : PubMed/NCBI